US stocks climbed on Friday to close a turbulent session in the green amid rising optimism for a December interest rate cut, ...

Eli Lilly surpassed a $1 trillion market capitalization this week. Why? Expectations-beating growth from Mounjaro and ...

A day after Thursday’s anxiety-inducing fake out, Friday turned into Redemption Day on Wall Street. The Dow ended the day 493 ...

Investors' initial euphoria gave way to selling as hopes for a December rate cut faded and bitcoin continued to sell off.

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock ...

The swift expansion of expensive AI infrastructure and the high capital demands for generative AI, in comparison to earlier ...

However, with investors celebrating the apparent breather in the AI storm, a very familiar voice has stepped back into the ...

The stock market’s fear gauge spiked to its highest levels in a month. The CBOE Volatility Index, or VIX, surged as high as ...

The U.S. stock market appeared geared up for a rebound after Nvidia’s stronger-than-expected earnings report after th ...

Last month it was circularity. This month, it's depreciation.

The tech juggernaut’s results sparked a furious rally, and then the largest blown gain since April’s tariff-fueled turmoil.

Cellebrite (CLBT) stays a long-term growth pick despite recent volatility and strong Q3 results. Read here for an investment ...